Combined application of BNLF2b antibody with VCA-IgA, Rta-IgG, and Zta-IgA in nasopharyngeal carcinoma screening in the Guangxi region.

PLoS One · 2025 · PMC12453175 · PMID 40982461

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

When compared with the four-marker panel, the combination showed a P value of 0.088 versus P85-Ab alone, close to marginal significance, suggesting a potential incremental advantage of combining multiple antibodies.

also in 5,069 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.